Flow cytometry in hematological disorders

Indian Journal of Pediatrics

Volumn 80, Issue 9, 2013, Pages 772-778

  Pati, Hara Prasad ^a   Jain, Sonal ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Anemia; Flow cytometry; Leukemia; Platelet disorders

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; BERNARD SOULIER DISEASE; CONFERENCE PAPER; FLOW CYTOMETRY; FLUORESCENCE; GLANZMANN DISEASE; HEMATOGONE; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HEMOPHAGOCYTIC SYNDROME; HUMAN; INBORN ERROR OF METABOLISM; INHERITED PLATELET DISORDER; LEUKOCYTE; LEUKOCYTE DISORDER; NONHODGKIN LYMPHOMA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PEDIATRICS; PRIMARY IMMUNODEFICIENCY DISORDER; PROGNOSIS; SCOTT SYNDROME; THROMBOCYTE; THROMBOCYTE DISORDER;

ANEMIA; ANEMIA, HEMOLYTIC; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; CHILD; ERYTHROCYTES; FLOW CYTOMETRY; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA; LEUKOCYTES; LYMPHOMA; MOLECULAR TARGETED THERAPY; PROGNOSIS;

EID: 84884356434     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-013-1152-2     Document Type: Conference Paper

References (41)

1. Shapiro HM. Practical Flow Cytometry. 4th ed. New York: Wiley Liss; 2003.
2. Michelson AD, Benoit SE, Furman MI, Bernard MR, Nurden P, Nurden AT. The platelet surface expression of glycoprotein V is regulated by two independent mechanisms: Proteolysis and a reversible cytoskeletal-mediated redistribution to the surface-connected canalicular system. Blood. 1996;87:1396-408.
3. Goodall AH, Appleby J. Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation. Methods Mol Biol. 2004;272:229-53.
4. Béné MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, et al. Immunophenotyping of acute leukemia and lymphoproliferative disorders: A consensus proposal of the European Leukemia Net Work Package 10. Leukemia. 2011;25:567-74.
5. Gujral S, Subramanian PG, Patkar N, Badrinath Y, Kumar A, Tembhare P, et al. Report of proceedings of the national meeting on "Guidelines for Immunophenotyping of Hematolymphoid Neoplasms by Flow Cytometry". Indian J Pathol Microbiol. 2008;51:161-6.
6. Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Lyon: International agency for Research on Cancer (IARC); 2008.
7. Raspadori D, Damiani D, Lenoci M, Rondelli D, Testoni N, Nardi G, et al. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia. 2001;15:1161-4.
8. Raspadori D, Lauria F, Ventura MA, Rondelli D, Visani G, de Vivo A, et al. Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: Analysis of 141 cases. Leuk Res. 1997;21:603-7.
9. Lin P, Hao S, Medeiros J, Estey EH, Pierce SA, Wang X, et al. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARα transcripts and poorer prognosis. Am J Clin Pathol. 2004;121:402-7.
10. Montesinos P, Rayón C, Vellenga E, Brunet S, González J, González M, et al. Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens. Blood. 2011;117:1799-805.
11. Campana D. Minimal residual disease analysis in acute lymphoblastic leukemia. Semin Hematol. 2009;46:100-6.
12. Salzburg J, Burkhardt B, Zimmermann M, Wachowski O, Woessmann W, Oschlies I, et al. Prevalence, clinical patterns, and outcome of CNS involvement in childhood and adolescent non Hodgkin's lymphoma differ by non hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster group report. J Clin Oncol. 2007;25:3915-22.
13. Meda BA, Buss DH, Woodruff RD, Cappellari JO, Rainer RO, Powell BL, et al. Diagnosis and subclassification of primary and recurrent lymphoma. The usefulness and limitations of combined fine-needle aspiration cytomorphology and flow cytometry. Am J Clin Pathol. 2000;113:688-99.
14. Demurtas A, Accinelli G, Pacchioni D, Godio L, Novero D, Bussolati G, et al. Utility of flow cytometry immunophenotyping in fine needle aspirate cytologic diagnosis of non hodgkin's lymphoma: A series of 252 cases and review of the literature. Appl Immunohistochem Mol Morphol. 2010;18:311-22. doi: 10.1097/PAI.0b013e3181827da8.
15. Barrena S, Almeida J, Del Carmen García-Macias M, López A, Rasillo A, Sayaques JM, et al. Flow cytometry immunophenotyping of fine-needle aspiration specimens: Utility in the diagnosis and classification of non-Hodgkin's lymphoma. Histopathology. 2011;58:906-18. doi: 10.1111/j.1365-2559.2011.03804.x.
16. Siena S, Bregni M, Di Nicola M, Peccatori F, Magni M, Brando B, et al. Milan Protocol for clinical CD 34+ cell estimation in peripheral blood for autografting in patients with cancer. In: Wunder E, Solvalat H, Henon PR, eds. Hematopoietic Stem Cells: The Millhouse Manual. Dayton: Alphamed; 1994. pp. 23-30.
17. Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol. 1994;22:1003-10.
18. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34 + cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213-26.
19. Reckzeh B, Grebe SO, Rhiele I, Neubauer A, Müller TF. Monitoring of ATG therapy by flow cytometry: Comparison of one single-platform and two different dual platform methods. Transplant Proc. 2001;33:2234-6.
20. Gorrie M, Thomson G, Lewis DM, Boyce M, Riad HN, Beaman M, et al. Dose titration during anti-thymocyte globulin therapy: Monitoring by CD3 count or total lymphocyte count? Clin Lab Haematol. 1997;19:53-6.
21. Clark KR, Forsythe JL, Shenton BK, Lennard TW, Proud G, Taylor RM. Administration of ATG according to the absolute T lymphocyte count during therapy for steroid resistant rejection. Transpl Int. 1993;6:18-21.
22. Hernandez-Trujillo VP, Fleisher TA. Interpretation of flow cytometry in primary immunodeficiency disorders. Ann Allergy Asthma Immunol. 2008;100:612-5.
23. King MJ, Behrens J, Rogers C, Flyn C, Greenwood D, Chambers K. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton associated hemolytic anaemia. Br J Haematol. 2000;111:924-33.
24. Kar R, Mishra P, Pati HP. Evaluation of eosin 5 maleimide flow cytometric test in diagnosis of hereditary spherocytosis. Int J Lab Hematol. 2010;32:8-16.
25. Won DI, Suh JS. Flow cytometric detection of erythrocyte osmotic fragility. Cytometry B Clin Cytom. 2009;76:135-41.
26. Shah SS, Diakiite SAS, Traorek K, Diakite M, Kwiatkowski DP, Rockett KA, et al. A novel cytofluorometric assay for the detection and quantification of glucose 6 phosphate dehydrogenase deficiency. Sci Rep. 2012;2:299.
27. Roys JL, Warzynski MJ. Estimation of "F-cell" populations. Cytometry B Clin Cytom. 2005;67:27-30.
28. Italia KY, Colah R, Mohanty D. Evaluation of F cells in sickle cell disorders by flow cytometry-comparison with the Kleihauer-Betke's slide method. Int J Lab Hematol. 2007;29:409-14.
29. Borowitz MJ, Craig FE, Digiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR, et al; Clinical Cytometry Society. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom. 2010;78:211-30.
30. Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, et al. British Committee for Standards in Hematology. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol. 2011;155:30-44.
31. George JN, Caen J-P, Nurden AT. Glanzmann's thrombasthenia: The spectrum of clinical disease. Blood. 1990;75:1383-95.
32. Nurden AT, George JN. Inherited abnormalities of the platelet membrane: glanzmann thrombasthenia, Bernard-Soulier syndrome, and other disorders. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis, Basic Principles and Clinical Practice. 6th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005.
33. Savoia A, Pastore A, De Rocco D, Civaschi E, Di Stazio M, Bottega R, et al. Clinical and genetic aspects of Bernard-Soulier syndrome: Searching for genotype/phenotype correlations. Haematologica. 2011;96:417-23.
34. Gordon N, Thom J, Cole C, Baker R. Rapid detection of hereditary and acquired storage pool deficiency by flow cytometry. Br J Haematol. 1995;89:117-23.
35. Wall JE, Buijs-Wilts M, Arnold JT, Wang W, White MM, Jennings LK, et al. A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents. Br J Haematol. 1995;89:380-5.
36. Kroft SH. Role of flow cytometry in pediatric hematopathology. Am J Clin Pathol. 2004;122:S19-32.
37. McKenna RW, Washington LT, Aquino DB, Picker LJ, Kroft SH. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood. 2001;98:2498-507.
38. Strauss SE, Sneller M, Lenardo MJ, Puck JM, Strober W, et al. An inherited disorder of lymphocyte apoptosis: The autoimmune lymphoproliferative syndrome. Ann Intern Med. 1999;130:591-661.
39. Bleesing JJ, Brown MR, Strauss SE, Dale JK, Siegel RM, Johnson M, et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood. 2001;98:2466-73.
40. Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002;99:61-6.
41. Arcio M, Allen M, Brusa S, Clementi R, Pende D, Maccario R, et al. Hemophagocytic lymphohistiocytosis: Proposal of adiagnostic algorithm based on perforin expression. Br J Haematol. 2002;119:180-8.